info@mail.ucallm.com
From Cell Cycle Control to Genome Integrity — Empowering Comprehensive Investigation of Cell Proliferation, DNA Damage Response & Mitotic Fidelity
Cell cycle progression is a highly coordinated biological process that ensures accurate genome duplication, chromosome segregation, and cellular proliferation. Precise regulation of cell cycle transitions, checkpoint activation, DNA repair mechanisms, and mitotic progression is essential for maintaining genomic stability and preventing uncontrolled cell growth.
The cell cycle is governed by interconnected regulatory networks involving:
- Cyclin–CDK signaling modules controlling cell cycle transitions
- DNA replication surveillance mechanisms
- DNA damage response (DDR) pathways
- G1/S and G2/M checkpoint activation
- Spindle assembly checkpoint (SAC) regulation
- Chromosome segregation and mitotic fidelity
- Cytokinesis and daughter cell formation
- Apoptosis and senescence-associated checkpoint responses
Dysregulation of cell cycle control contributes to multiple pathological processes, including:
- Cancer initiation and tumor progression
- Chromosomal instability and genomic evolution
- Therapy resistance
- Developmental abnormalities
- Aging-associated cellular dysfunction
- DNA damage accumulation and senescence
Our validated antibody solutions enable researchers to move beyond single-marker detection toward integrated profiling of cell cycle progression, checkpoint activation, mitotic regulation, and genome stability mechanisms.
Supporting applications include:
- Cell proliferation analysis
- Cell cycle phase characterization
- DNA damage and repair studies
- Cancer biology and therapeutic response evaluation
- Mitotic defect investigation
- Drug-induced cell cycle arrest analysis
- Functional validation of cell cycle regulators
Cell Cycle & Mitotic Checkpoint Antibody Portfolio
—Comprehensive Solutions for Cell Cycle Profiling, Checkpoint Regulation & Genome Stability Research
Cell cycle regulation requires coordinated control of molecular switches that regulate DNA replication, chromosome segregation, and mitotic progression.
Our antibody portfolio enables comprehensive characterization of:
Research Focus | Representative Targets | Biological Interpretation & Research Applications |
Cell Proliferation & Cell Cycle Identity | Ki-67 , PCNA , MCM2 , MCM7 , Geminin | Defines proliferative activity, DNA replication competence, and cell cycle status in tissues and cellular models |
G1/S Cell Cycle Transition Network | CCND1, CDK4, CDK6, RB1, pRB1 Ser807/811, E2F1, CCNE1, CDK2, CDKN1A/p21, CDKN1B/p27 | Controls commitment to DNA replication and regulates proliferation entry through RB–E2F signaling |
S Phase DNA Replication Network | Cyclin A2 , CDK2 , PCNA , MCM2, MCM3, MCM7 , RPA | Characterizes DNA synthesis, replication fork progression, and replication stress responses |
G2/M Transition Regulation Network | CCNB1, CDK1, pCDK1 Tyr15, CDC25A/B/C, WEE1, PKMYT1, PLK1 | Regulates mitotic entry, CDK activation, and checkpoint-mediated control of mitotic initiation |
Mitotic Progression & Chromosome Segregation | Aurora A , Aurora B , PLK1 , INCENP , Survivin | Investigates centrosome maturation, chromosome alignment, kinetochore function, and cytokinesis |
Spindle Assembly Checkpoint (SAC) Network | MAD2L1, BUB1, BUB1B/BubR1, BUB3, CDC20, TTK/MPS1, CENP-E | Monitors chromosome attachment and prevents premature anaphase progression |
DNA Damage Checkpoint Network | ATM , ATR , CHK1 , CHK2 , p53 , p21 | Defines DNA damage sensing, checkpoint activation, and genome protection mechanisms |
DNA Repair & Genome Stability Network | γH2AX , 53BP1 , BRCA1 , RAD51 , MDC1 | Characterizes DNA double-strand break repair, homologous recombination, and genomic maintenance |
Cell Cycle Arrest & Senescence Network | CDKN2A/p16INK4A, CDKN1A/p21, TP53, LMNB1, H2AFX pSer139, IL6, IL8, MMP3 | Investigates irreversible growth arrest, cellular aging, and stress-induced senescence |
Cell Cycle–Apoptosis Crosstalk | BAX , BCL-2 , Cleaved Caspase-3 , PARP | Links checkpoint failure with apoptotic elimination following cellular stress |
Cell Cycle Regulatory Network
—Master Regulatory Programs Controlling Proliferation, Genome Integrity & Mitotic Fidelity
Cell cycle progression is orchestrated by hierarchical regulatory networks integrating growth signals, DNA replication status, checkpoint activation, and mitotic machinery.
Regulatory Network | Representative Targets | Biological Interpretation & Research Applications |
Cyclin–CDK Cell Cycle Engine | Cyclin D1, Cyclin E, Cyclin A2, Cyclin B1, CDK2, CDK4/6, CDK1 | Central molecular oscillator driving sequential progression through G1, S, G2, and M phases |
RB–E2F G1/S Restriction Point Network | RB, p-RB, E2F1, Cyclin D1, CDK4/6 | Controls cell cycle commitment and transcriptional activation required for DNA replication |
ATM–ATR DNA Damage Response Network | ATM, ATR, CHK1, CHK2, p53 | Detects DNA damage and activates checkpoint signaling to preserve genome integrity |
p53 Tumor Suppressor Checkpoint Network | p53, p-p53, MDM2, p21, GADD45 | Mediates DNA damage-induced cell cycle arrest, repair, senescence, or apoptosis |
Replication Stress Response Network | RPA, ATR, CHK1, PCNA, RAD51 | Maintains replication fork stability and prevents replication-associated genome instability |
Spindle Assembly Checkpoint Network | MAD2, BUB1, BUBR1, CDC20, CENP proteins | Ensures accurate chromosome segregation by monitoring kinetochore–microtubule attachment |
Mitotic Kinase Regulatory Network | PLK1, Aurora A, Aurora B, CDK1 | Controls chromosome condensation, spindle formation, and mitotic progression |
Chromatin & Epigenetic Cell Cycle Regulation | EZH2, HDACs, DNMT1, H3K27me3 | Links chromatin remodeling with proliferation, differentiation, and tumor progression |
Cell Cycle–Apoptosis Decision Network | BCL-2, BAX, Caspase-3, PARP | Determines cellular fate following checkpoint activation or mitotic failure |
Featured Cell Cycle Research Panels
—Comprehensive Antibody Panels for Mapping Cell Proliferation, Checkpoint Activation & Mitotic Regulation
Cell cycle progression is governed by interconnected regulatory networks that coordinate cell growth, DNA replication, checkpoint activation, chromosome segregation, and cellular fate decisions.These focused antibody panels enable multiparametric characterization of cell cycle regulation across physiological and disease contexts, supporting research in:
- Cell proliferation and cell cycle progression
- DNA replication and replication stress
- DNA damage response and checkpoint activation
- Mitotic entry and chromosome segregation
- Cancer-associated cell cycle dysregulation
- Therapeutic-induced cell cycle arrest and apoptosis
Cell Proliferation & Cell Cycle Status Panel—Define proliferative capacity and cell cycle distribution
Ki-67 | PCNA | MCM2 | MCM7 | Geminin | Cyclin D1 |
Cell Cycle Arrest, Senescence & Cellular Fate Panel—Connect checkpoint activation with irreversible growth arrest and cellular aging
GLB1 | γH2AX | Lamin B1 | p16 | p53 | p21 |
Mitotic Progression & Chromosome Segregation Panel—Analyze spindle assembly and chromosome dynamics
Aurora A | Aurora B | PLK1 | BUB1 | BUBR1 | MAD2 | CDC20 | CENP-A |
Replication Stress & Genome Stability Panel—Evaluate replication-associated damage and repair pathways
PCNA | RPA | RAD51 | BRCA1 | FANCD2 | γH2AX |
Cancer Cell Cycle Dysregulation Panel—Investigate oncogenic proliferation mechanisms and therapeutic vulnerabilities
Cyclin D1 | CDK4 | CDK6 | Cyclin E1 | RB/p-RB |
E2F1 | PLK1 | Aurora B | Ki-67 |
|
Why Researchers Choose Our Cell Cycle & Mitotic Checkpoint Research Solutions
Integrated Antibody Solutions for Mapping Proliferation Dynamics, Checkpoint Regulation & Genome Stability
Cell cycle research requires multidimensional analysis beyond proliferation markers alone.
Our validated antibody portfolio enables researchers to investigate:
Research Question | Integrated Antibody Solution |
How can I determine cell proliferation status? | Ki-67, PCNA, MCM proteins combined with Cyclin expression profiling |
How can I identify cell cycle phase transitions? | Cyclin D/E/A/B and CDK pathway analysis across G1/S/G2/M phases |
How can I investigate DNA damage responses? | γH2AX, 53BP1, ATM/ATR, CHK signaling pathway profiling |
How can I analyze mitotic defects? | Aurora kinase, PLK1, CENP proteins and spindle checkpoint markers |
How can I study cancer-associated cell cycle dysregulation? | RB–E2F, Cyclin-CDK, p53 checkpoint and proliferation panels |
How can I evaluate therapeutic-induced cell cycle arrest? | Checkpoint activation, apoptosis markers, and mitotic progression analysis |
How can I perform spatial cell cycle profiling? | Multiplex IF/IHC-compatible antibody solutions for tissue architecture analysis |
Key References
Matthews HK, Bertoli C, de Bruin RAM. Cell cycle control in cancer.Nature Reviews Molecular Cell Biology. 2022;23:74–88.
McAinsh AD, Kops GJPL. Principles and dynamics of spindle assembly checkpoint signalling.Nature Reviews Molecular Cell Biology. 2023;24:543–559.
Groelly FJ, Fawkes M, Dagg RA, et al. Targeting DNA damage response pathways in cancer. Nature Reviews Cancer. 2023;23:78–94.
Cybulla E, Vindigni A. Leveraging the replication stress response to optimize cancer therapy.Nature Reviews Cancer. 2023;23:6–24.
Li Q, Qian W, Zhang Y, et al. A new wave of innovations within the DNA damage response. Signal Transduction and Targeted Therapy. 2023;8:338.